Since HMGCS2 is the rate-limiting gene in the ketone body production pathway [18], we further investigated whether HMGCS2 gene expression influences HCC progression in a ketone-dependent manner. The gene discussed is HMGCS2; the disease is hepatocellular carcinoma.